Responses
Clinical and epidemiological research
Extended report
Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis
Compose a Response to This Article
Other responses
No responses have been published for this article.